Snapshot
The FDA Orphan Designation pathway has been developed by the US Food and Drug Administration of United States.
This pathway accelerates the regulatory review process.
It is an abridged review (a reliance pathway).
Info not found
The FDA Orphan Designation pathway has been developed by the US Food and Drug Administration of United States.
This pathway accelerates the regulatory review process.
It is an abridged review (a reliance pathway).
Info not found